Cunchuan Chen, Huifang Zhang, Xia Feng, Haipeng Wang
{"title":"Factors Influencing the Use and Demand of New Coronavirus Therapy Drugs Among the Adults During COVID-19 in China","authors":"Cunchuan Chen, Huifang Zhang, Xia Feng, Haipeng Wang","doi":"10.2147/rmhp.s468700","DOIUrl":null,"url":null,"abstract":"<strong>Background:</strong> This alteration in the policy of COVID-19 resulted in widespread infections throughout China. Most people only need some antiviral drugs such as lopinavir/ritonavir or Chinese herbal preparations for treatment. In this context, the lack of drug knowledge and inadequate drug availability are evident. This study aims to explore the factors influencing drug use and demand during the COVID-19 epidemic.<br/><strong>Methods:</strong> This study used quota sampling based on gender, age, and place of residence to perform a cross-sectional survey on a sample of 771 adults. The researchers used chi-square tests to understand differences in drug use and demand across characteristics, and binary logistic regression to analyse the influencing factors.<br/><strong>Results:</strong> The study revealed that 85.9% of the participants used drugs following the COVID-19 infection. Participants with college and above, (OR=2.49, 95% CI=1.27– 4.88) annual personal income between 30,000 and 80,000CNY (OR=2.19, 95% CI=1.35– 3.55) and over 80,000CNY (OR=1.96, 95% CI=1.05– 3.66) were more knowledgeable about using drugs. Gender, (OR=0.69, 95% CI=0.50– 0.95) age, (OR=2.11, 95% CI=1.15– 3.88) residence, (OR=1.58, 95% CI=1.06– 2.37) chronic disease conditions (OR=0.46, 95% CI=0.27– 0.78) and infection symptoms (OR=0.60, 95% CI=0.38– 0.93) as factors influencing the need for drug delivery services. (P< 0.05).<br/><strong>Conclusion:</strong> Research has revealed that a significant proportion of infected people in China chose drug treatment during COVID-19. Individuals with severe symptoms use more medication and require more drug delivery and storage. Low-education and low-income populations are lacking in drug knowledge, and older adults with underlying medical conditions are more likely to need drug delivery services. Therefore, governments should prioritize vulnerable groups when formulating drug policies and target drug literacy and guidance. In addition, it is recommended that a drug distribution system be set up within the community so that those in need can have quick and easy access to drugs.<br/><br/>","PeriodicalId":56009,"journal":{"name":"Risk Management and Healthcare Policy","volume":"80 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Risk Management and Healthcare Policy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/rmhp.s468700","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: This alteration in the policy of COVID-19 resulted in widespread infections throughout China. Most people only need some antiviral drugs such as lopinavir/ritonavir or Chinese herbal preparations for treatment. In this context, the lack of drug knowledge and inadequate drug availability are evident. This study aims to explore the factors influencing drug use and demand during the COVID-19 epidemic. Methods: This study used quota sampling based on gender, age, and place of residence to perform a cross-sectional survey on a sample of 771 adults. The researchers used chi-square tests to understand differences in drug use and demand across characteristics, and binary logistic regression to analyse the influencing factors. Results: The study revealed that 85.9% of the participants used drugs following the COVID-19 infection. Participants with college and above, (OR=2.49, 95% CI=1.27– 4.88) annual personal income between 30,000 and 80,000CNY (OR=2.19, 95% CI=1.35– 3.55) and over 80,000CNY (OR=1.96, 95% CI=1.05– 3.66) were more knowledgeable about using drugs. Gender, (OR=0.69, 95% CI=0.50– 0.95) age, (OR=2.11, 95% CI=1.15– 3.88) residence, (OR=1.58, 95% CI=1.06– 2.37) chronic disease conditions (OR=0.46, 95% CI=0.27– 0.78) and infection symptoms (OR=0.60, 95% CI=0.38– 0.93) as factors influencing the need for drug delivery services. (P< 0.05). Conclusion: Research has revealed that a significant proportion of infected people in China chose drug treatment during COVID-19. Individuals with severe symptoms use more medication and require more drug delivery and storage. Low-education and low-income populations are lacking in drug knowledge, and older adults with underlying medical conditions are more likely to need drug delivery services. Therefore, governments should prioritize vulnerable groups when formulating drug policies and target drug literacy and guidance. In addition, it is recommended that a drug distribution system be set up within the community so that those in need can have quick and easy access to drugs.
期刊介绍:
Risk Management and Healthcare Policy is an international, peer-reviewed, open access journal focusing on all aspects of public health, policy and preventative measures to promote good health and improve morbidity and mortality in the population. Specific topics covered in the journal include:
Public and community health
Policy and law
Preventative and predictive healthcare
Risk and hazard management
Epidemiology, detection and screening
Lifestyle and diet modification
Vaccination and disease transmission/modification programs
Health and safety and occupational health
Healthcare services provision
Health literacy and education
Advertising and promotion of health issues
Health economic evaluations and resource management
Risk Management and Healthcare Policy focuses on human interventional and observational research. The journal welcomes submitted papers covering original research, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary, and extended reports. Case reports will only be considered if they make a valuable and original contribution to the literature. The journal does not accept study protocols, animal-based or cell line-based studies.